Literature DB >> 9029506

Maturation of receptor proteins in eukaryotic expression systems.

H M Sadeghi1, G Innamorati, M Birnbaumer.   

Abstract

Transient and stable expression in eukaryotic cells is commonly used to examine receptor function. Characterization of the V2 vasopressin receptor synthesized in transiently transfected cells revealed the presence of large quantities of immature protein and a small fraction of fully mature protein. The immature protein was characterized by its sensitivity to endoglycosidase H treatment, abnormal migration in SDS PAGE, and a tendency to form aggregates. Prevention of protein glycosylation by mutagenesis increased the fraction of mature protein produced, but did not eliminate the need for the maturation step. On the other hand, stably transfected cells produce almost exclusively mature receptor protein with a t1/2 of 6 h, while the immature form has a t1/2 of 20 min. In the absence of N-linked glycosylation the t1/2 of the mature V2 receptor in stably transfected cells was reduced to 4.5 h. In transient expression experiments the immature receptor proteins exhibited a prolonged t1/2 of about 8 h. Comparison of the half life of the immature form of the wild type and the R137H mutant V2 receptor did not reveal differences despite the lower amounts of mutant mature receptor detected by binding.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029506     DOI: 10.3109/10799899709036619

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  6 in total

1.  Analysis of a novel AVPR2 mutation in a family with nephrogenic diabetes insipidus.

Authors:  Sung-Dae Moon; Ju-Hee Kim; Joo-Yun Shim; Dong-Jun Lim; Bong-Yun Cha; Je-Ho Han
Journal:  Int J Clin Exp Med       Date:  2010-11-30

2.  Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor.

Authors:  Larry S Barak; Ali Salahpour; Xiaodong Zhang; Bernard Masri; Tatyana D Sotnikova; Amy J Ramsey; Jonathan D Violin; Robert J Lefkowitz; Marc G Caron; Raul R Gainetdinov
Journal:  Mol Pharmacol       Date:  2008-06-04       Impact factor: 4.436

3.  Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists.

Authors:  Joris H Robben; Marleen L A Kortenoeven; Mozes Sze; Chris Yae; Graeme Milligan; Viola M Oorschot; Judith Klumperman; Nine V A M Knoers; Peter M T Deen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-08       Impact factor: 11.205

4.  Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus.

Authors:  L S Barak; R H Oakley; S A Laporte; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

5.  Thioacylation is required for targeting G-protein subunit G(o1alpha) to detergent-insoluble caveolin-containing membrane domains.

Authors:  F Guzzi; D Zanchetta; B Chini; M Parenti
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

6.  Characterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation.

Authors:  Federica Prosperi; Yoko Suzumoto; Pierluigi Marzuillo; Vincenzo Costanzo; Sabina Jelen; Anna Iervolino; Stefano Guarino; Angela La Manna; Emanuele Miraglia Del Giudice; Alessandra F Perna; Miriam Zacchia; Emmanuelle Cordat; Giovambattista Capasso; Francesco Trepiccione
Journal:  Sci Rep       Date:  2020-10-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.